BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 30, 2017
View Archived Issues
Hair follicle stem cell metabolism can be exploited to activate the hair cycle
Read More
AstraZeneca and Takeda partner to develop and commercialize MEDI-1341 for Parkinson's disease
Read More
Boston Pharmaceuticals licenses Daiichi's DS-5010
Read More
Seattle Genetics exercises option to codevelop tisotumab vedotin with Genmab
Read More
Moleculin files IND to study annamycin for relapsed or refractory AML
Read More
Combination of TRC-105 plus sorafenib demonstrates promising safety and efficacy in HCC
Read More
Acorda receives refusal to file letter from FDA regarding Inbrija NDA
Read More
FDA grants rare pediatric disease designation to Prometic's Ryplazim
Read More
FDA grants fast track designation for MitoGel for the treatment of upper tract urothelial carcinoma
Read More
Celgene exercises option to extend collaboration with Forma
Read More
Jazz Pharmaceuticals and ImmunoGen enter strategic collaboration and option agreement
Read More
Mydayis now available in U.S.
Read More
Bristol-Myers Squibb selectively targets TYK2 for autoimmune, inflammatory diseases
Read More
Anthera reports topline data from BRIGHT-SC extension of blisibimod in IgA nephropathy
Read More
GlobeImmune announces clinical program updates
Read More
Selective 5-HT2B receptor antagonists derived at AnaMar AB to treat fibrosis
Read More
Mologen signs binding term sheet for lefitolimod collaboration with iPharma
Read More
miR-92a identified as a potential biomarker of rapid aortic valve calcification
Read More
Redx Pharma identifies compounds for treating mycobacterial infections
Read More
FDA grants breakthrough therapy designation to EB-101 for recessive dystrophic epidermolysis bullosa
Read More
FDA grants breakthrough therapy designation to DS-8201 for HER2-positive metastatic breast cancer
Read More
European Molecular Biology Laboratory, Savira Pharmaceuticals divulge compounds for influenza
Read More
Mazor Robotics and Medtronic enter next phase of strategic partnership
Read More
Thermo Fisher Scientific announces completion of its acquisition of Patheon
Read More
Immix closes Series A financing to support lead candidate Imx-110
Read More
FDA accepts for priority review BioMarin's BLA for pegvaliase for PKU
Read More
Apricus resubmits Vitaros NDA
Read More
FDA grants accelerated approval to benznidazole for children with Chagas disease
Read More
